NCT02221505View on ClinicalTrials.gov

Phase 1 Study of LOP628 in Adult Patients With cKit-positive Solid Tumors and Acute Myeloid Leukemia

PHASE1TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
cKIT-positive Solid TumorsAML
Interventions
DRUG

LOP628

Trial Locations (4)

3000

Novartis Investigative Site, Leuven

3050

Novartis Investigative Site, Parkville

2300 RC

Novartis Investigative Site, Leiden

08035

Novartis Investigative Site, Barcelona

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY